We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$434M
AUM Growth
+$72.4M
Cap. Flow
+$84.9M
Cap. Flow %
19.57%
Top 10 Hldgs %
81.24%
Holding
46
New
12
Increased
6
Reduced
2
Closed
10

Top Buys

1
KYNB
Kyntra Bio
KYNB
+$43M
2
FBRX icon
Forte Biosciences
FBRX
+$22.5M
3
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$16.5M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$14.7M
5
EDIT icon
Editas Medicine
EDIT
+$12.9M

Top Sells

1
ACRS icon
Aclaris Therapeutics
ACRS
+$13.3M
2
ATRA icon
Atara Biotherapeutics
ATRA
+$8.94M
3
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
+$5.68M
4
XNCR icon
Xencor
XNCR
+$5.62M
5
KURA icon
Kura Oncology
KURA
+$5.26M

Sector Composition

1 Healthcare 96.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
1
Ironwood Pharmaceuticals
IRWD
$663M
$70.9M 16.35%
4,481,840
+1,012,655
+29% +$14.7M
ASMB icon
2
Assembly Biosciences
ASMB
$528M
$60.8M 14.02%
245,264
– –
KYNB
3
Kyntra Bio
KYNB
$30M
$51.2M 11.81%
63,418
+61,738
+3,675% +$43M
LKFT
4
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
$44.3M 10.21%
578,505
+27,464
+5% +$2.31M
ASND icon
5
Ascendis Pharma A/S
ASND
$17.4B
$41.2M 9.49%
1,482,600
+456,900
+45% +$12.1M
SGMO
6
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$22.6M 5.21%
+2,568,119
New +$16.5M
KURA icon
7
Kura Oncology
KURA
$1B
$18.9M 4.36%
2,033,622
-578,284
-22% -$5.26M
FBRX icon
8
Forte Biosciences
FBRX
$891M
$18.1M 4.17%
+4,006
New +$22.5M
CTMX icon
9
CytomX Therapeutics
CTMX
$790M
$12.3M 2.84%
794,969
– –
EDIT icon
10
Editas Medicine
EDIT
$480M
$12M 2.78%
+717,107
New +$12.9M
CASC
11
DELISTED
Cascadian Therapeutics, Inc.
CASC
$11.1M 2.57%
3,000,000
– –
CRVS icon
12
Corvus Pharmaceuticals
CRVS
$1.26B
$9.74M 2.25%
+805,000
New +$8.59M
FATE icon
13
Fate Therapeutics
FATE
$345M
$8.22M 1.9%
2,537,026
– –
ATYR
14
aTyr Pharma
ATYR
$54M
$7.79M 1.8%
163,761
– –
TPST icon
15
Tempest Therapeutics
TPST
$16.3M
$5.48M 1.26%
1,201
– –
ACRS icon
16
Aclaris Therapeutics
ACRS
$772M
$5.03M 1.16%
185,472
-487,628
-72% -$13.3M
KIN
17
DELISTED
Kindred Biosciences, Inc.
KIN
$4.69M 1.08%
544,880
– –
TTPH
18
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$4.52M 1.04%
+31,670
New +$4.89M
RGLS
19
DELISTED
Regulus Therapeutics
RGLS
$3.66M 0.84%
30,910
+18,327
+146% +$3.06M
ACHN
20
DELISTED
Achillion Pharmaceuticals
ACHN
$3.41M 0.79%
+742,835
New +$2.99M
NBRV
21
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$2.77M 0.64%
1,059
– –
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.44M 0.56%
767,992
+385,992
+101% +$1.22M
ADVM
23
DELISTED
Adverum Biotechnologies
ADVM
$2.19M 0.5%
87,445
– –
NERV icon
24
Minerva Neurosciences
NERV
$196M
$1.98M 0.46%
+27,975
New +$1.81M
BHVN
25
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.75M 0.4%
+70,000
New +$1.61M
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return